TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18185145

Group type: EXPERIMENTAL
Intervention: Macular grid laser photocoagulation (MGLP)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: MGLP
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control
Number of subjects: 31
Study: 16395369

Group type: COMPARATOR
Intervention: MOD inlay preparation (Group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Modified PCR (Group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Modified PCR (Group C)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Modified PCR (Group D)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Modified PCR (Group E)
Number of subjects: 80
Study: 14595300

Group type: EXPERIMENTAL
Intervention: Endoscopic therapy for Forrest Ib‐IIb ulcers with positive Doppler signal
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Endoscopic therapy for Forrest IIc‐III ulcers with positive Doppler signal
Number of subjects: 80

Group type: COMPARATOR
Intervention: No therapy for Forrest IIc‐III ulcers with positive Doppler signal
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Doppler signal present after endoscopic therapy
Number of subjects: 80
Study: 10584158

Group type: COMPARATOR
Intervention: Placebo-controlled trials (PCTs)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nonplacebo-controlled trials (NPCTs)
Number of subjects: 8
Study: 8707096

Group type: EXPERIMENTAL
Intervention: 5 MU injections (group A)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: 1.5 MU injections (group B)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Increasing the dose of interferon in group B
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: 1.5 MU injections (group B) with normal ALT
Number of subjects: 141
Study: 2735516

Group type: EXPERIMENTAL
Intervention: Oral 'booster' (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 20
Study: 1106229

Group type: EXPERIMENTAL
Intervention: DFD-Py
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: DDS-Py
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: DFD alone
Number of subjects: 659

Group type: COMPARATOR
Intervention: Py alone
Number of subjects: 659

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 659
Study: 30973053

Group type: EXPERIMENTAL
Intervention: Transfusion threshold
Number of subjects: 181

Group type: COMPARATOR
Intervention: GOS and GOS-E
Number of subjects: 181

Group type: COMPARATOR
Intervention: Ordinal logistic regression or sliding dichotomy method
Number of subjects: 181
Study: 28160772

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 26579625

Group type: EXPERIMENTAL
Intervention: Reactive jump training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-specific training (Control)
Number of subjects: 21
Study: 23287787

Group type: EXPERIMENTAL
Intervention: Top 2 tHcy quartiles (Q3 and Q4)
Number of subjects: 1327
Study: 21215382

Group type: EXPERIMENTAL
Intervention: Telehealth lifestyle counseling (active control plus 6 weekly 1‐hour teleconferenced sessions to groups of 4 to 8 subjects)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Active control (risk factor feedback, brief advice, handouts)
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Telehealth lifestyle counseling
Number of subjects: 680

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Both groups (Telehealth and Active control)
Number of subjects: 680
Study: 18553130

Group type: EXPERIMENTAL
Intervention: Patients with depression
Number of subjects: 500

Group type: COMPARATOR
Intervention: Patients without depression
Number of subjects: 500
Study: 23027490

Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw fixation
Number of subjects: 108

Group type: COMPARATOR
Intervention: Bilateral pedicle screw fixation
Number of subjects: 108
Study: 16053970

Group type: EXPERIMENTAL
Intervention: Ambrisentan 1 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ambrisentan 2.5 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ambrisentan 5 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ambrisentan 10 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ambrisentan (all doses combined)
Number of subjects: 64
Study: 12449286

Group type: EXPERIMENTAL
Intervention: Intensive Intervention Program (IIP) with motivational interviewing contacts from a dietitian
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual WHI Dietary Modification (DM) Intervention
Number of subjects: 175

Group type: COMPARATOR
Intervention: Overall difference between IIP intervention and control
Number of subjects: 175
Study: 9880769

Group type: EXPERIMENTAL
Intervention: Chemotherapy (5-fluorouracil-based)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy (various drugs including gemcitabine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study: 7701406

Group type: EXPERIMENTAL
Intervention: Low Molecular Weight Heparin (LMWH)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard Heparin (UFH)
Number of subjects: 43
Study: 2730380

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 791101

Group type: EXPERIMENTAL
Intervention: Cephalothin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cephapirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water control
Number of subjects: 0
Study: 30593164

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27855723

Group type: EXPERIMENTAL
Intervention: Self-referral pathway
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: In-consultation pathway
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Self-referral and in-consultation pathways
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Practice deprivation
Number of subjects: 197

Group type: COMPARATOR
Intervention: Practice list size
Number of subjects: 197

Group type: COMPARATOR
Intervention: Practice deprivation decile
Number of subjects: 197
Study: 25001950

Group type: EXPERIMENTAL
Intervention: Testosterone reactivity on the first day (competition effect)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone reactivity on the second day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone fluctuations on the second day in unstable hierarchies
Number of subjects: 0
Study: 22278973

Group type: EXPERIMENTAL
Intervention: Blonanserin (8 weeks)
Number of subjects: 24
Study: 21214105

Group type: EXPERIMENTAL
Intervention: Amiodarone (5 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 120
Study: 18661524

Group type: EXPERIMENTAL
Intervention: Yttrium-90-labeled murine HMFG1 plus standard treatment (AT)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Standard treatment alone (ST)
Number of subjects: 407
Study: 16038388

Group type: EXPERIMENTAL
Intervention: Mild to moderate hypothermia (32 degrees‐28 degrees C) during CABG surgery
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Patients with HIPA
Number of subjects: 45

Group type: COMPARATOR
Intervention: Patients without HIPA
Number of subjects: 45
Study: 12439651

Group type: EXPERIMENTAL
Intervention: Walking 30 min, 5 days per week (DEX1)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Walking 60 min, 5 days per week (DEX2)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Diet only control group (DO)
Number of subjects: 56
Study: 10363736

Group type: EXPERIMENTAL
Intervention: Loracarbef (15 mg/kg)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Clarithromycin (7.5 mg/kg)
Number of subjects: 334
Study: 7572831

Group type: EXPERIMENTAL
Intervention: 8-session preventive intervention program
Number of subjects: 271

Group type: COMPARATOR
Intervention: Delayed treatment condition
Number of subjects: 271
Study: 2115287

Group type: EXPERIMENTAL
Intervention: Upright position exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Supine position exercise
Number of subjects: 30
Study: 7234386

Group type: EXPERIMENTAL
Intervention: Pooled human milk feeding regimen, protein intake: 2.0 g/kg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cow's milk based infant formula feeding regimen, protein intake: 4.4 g/kg/day
Number of subjects: 20
Study: 31939511

Group type: EXPERIMENTAL
Intervention: Virtual Learning Environment (VLE) - six virtual pediatric rheumatology modules
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group - only answered the pre-course test and post-course test after 4 weeks
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Satisfaction with VLE use
Number of subjects: 92
Study: 31097609

Group type: EXPERIMENTAL
Intervention: Nurse-led CKD management program in intervention practices
Number of subjects: 23657

Group type: COMPARATOR
Intervention: Usual CKD care in control practices
Number of subjects: 23657
Study: 28229374

Group type: EXPERIMENTAL
Intervention: Short-term fasting (36 hours)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (overnight fast)
Number of subjects: 12
Study: 26352793

Group type: EXPERIMENTAL
Intervention: Tissue-saving group (Technolas 217z Zyoptix laser; Bausch & Lomb)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wavefront-optimized group (WaveLight Allegretto Wave Eye‐Q laser; Alcon Laboratories)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tissue-saving group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wavefront-optimized group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 22960802

Group type: EXPERIMENTAL
Intervention: Telephone-based case-management intervention
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 268
Study: 21299844

Group type: EXPERIMENTAL
Intervention: Paliperidone ER 6-12 mg/day
Number of subjects: 421

Group type: COMPARATOR
Intervention: Risperidone 2-4 mg/day
Number of subjects: 421

Group type: COMPARATOR
Intervention: Risperidone 4-6 mg/day
Number of subjects: 421
Study: 20024739

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) use
Number of subjects: 871
Study: 17901665

Group type: EXPERIMENTAL
Intervention: Fortified EBM
Number of subjects: 0

Group type: COMPARATOR
Intervention: EBM only
Number of subjects: 0
Study: 12709690

Group type: EXPERIMENTAL
Intervention: Synthetic porcine secretin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 29
Study: 10736079

Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation (n=14)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Controlled mechanical ventilation (CMV) (n=16)
Number of subjects: 30
Study: 8874661

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 100 micrograms OD
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 200 micrograms OD
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 200 micrograms twice daily
Number of subjects: 501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study: 1527157

Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg, t.i.d. for 3 weeks before surgery and added to cardioplegic solutions at 10(-6) M)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 4014786

Group type: EXPERIMENTAL
Intervention: MDI-metaproterenol
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Placebo-inhaler with inert ingredients
Number of subjects: 1450
Study: 30902603

Group type: EXPERIMENTAL
Intervention: Tapered implants
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cylindrical implants
Number of subjects: 50
Study: 29435810

Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation (PP-SV) with inspiratory pressure of 8 cmH2O, positive end-expiratory pressure of 10 cmH2O, and fraction of inspired oxygen of 0.21
Number of subjects: 17

Group type: COMPARATOR
Intervention: Spontaneous ventilation at zero inspiratory pressure (ZEEP-SV)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Reverse Trendelenburg position (RT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Beach chair position (BC)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Supine position (S)
Number of subjects: 17
Study: 27040472

Group type: EXPERIMENTAL
Intervention: Physically active academic lessons (22-week intervention program)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 376
Study: 25088030

Group type: EXPERIMENTAL
Intervention: Community-based exercise program (CBE)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (unsupervised habitual physical activity)
Number of subjects: 19
Study: 22536889

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 150
Study: 21591384

Group type: EXPERIMENTAL
Intervention: 1 g/day omega-3 polyunsaturated fatty acids for 1 month
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 1 g/day omega-3 polyunsaturated fatty acids continued for a second month
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 1 g/day omega-3 polyunsaturated fatty acids stopped after one month
Number of subjects: 43
Study: 19419925

Group type: EXPERIMENTAL
Intervention: Paclitaxel and docetaxel (standard therapies)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer taxanes (in development)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel taxanes (single agents and in combination regimens)
Number of subjects: 0
Study: 15915295

Group type: EXPERIMENTAL
Intervention: Trained residents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caretakers of pediatric patients seen by intervention residents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untrained residents
Number of subjects: 0
Study: 11836041

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Raloxifene 150 mg
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: ccHRT (conjugated equine estrogens 0.625 mg plus medroxyprogesterone acetate 2.5 mg)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 9817623

Group type: EXPERIMENTAL
Intervention: Lithium + desipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo + desipramine
Number of subjects: 0
Study: 18800454

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Captopril (50 mg)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg) and Captopril (50 mg)
Number of subjects: 163
Study: 2766724

Group type: EXPERIMENTAL
Intervention: Prentif cervical cap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diaphragm
Number of subjects: 0
Study: 651595

Group type: EXPERIMENTAL
Intervention: Unik
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Unibaryt
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Micropaque
Number of subjects: 198

Group type: COMPARATOR
Intervention: Barex‐Coat‐S
Number of subjects: 198
Study: 31780587

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) + usual care
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 124
Study: 29380563

Group type: EXPERIMENTAL
Intervention: CD34+ cell therapy (Stem Cells Group, n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No cell therapy (Controls, n=30)
Number of subjects: 60
Study: 26786756

Group type: EXPERIMENTAL
Intervention: Aluminium oxide (Al2O3) exposure (3.8-4.0 mg/m3) for 2 hours including 30 minutes of exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aluminium oxide (Al2O3) exposure
Number of subjects: 15

Group type: COMPARATOR
Intervention: Clean air exposure (control)
Number of subjects: 15
Study: 24214244

Group type: EXPERIMENTAL
Intervention: Learning to quilt for an average of 16.51 hr a week for 3 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Learning digital photography for an average of 16.51 hr a week for 3 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engaging in both activities (quilting and digital photography) for an average of 16.51 hr a week for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Receptive-engagement conditions (nonintellectual activities with a social group or low-demand cognitive tasks with no social contact)
Number of subjects: 0
Study: 22108921

Group type: COMPARATOR
Intervention: Clamp (CL)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Clamp-free device (HS)
Number of subjects: 57
Study: 20854563

Group type: EXPERIMENTAL
Intervention: High levels of general fatigue, physical fatigue
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Use of assistive devices
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Use of home help
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Use of community mobility services
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Activities of daily living (ADL) performance
Number of subjects: 40
Study: 17177576

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Switching to aripiprazole from maintenance therapy with another antipsychotic
Number of subjects: 0
Study: 15516167

Group type: EXPERIMENTAL
Intervention: Infant orthopedics (IO+) - wearing a plate till surgical closure of the soft palate
Number of subjects: 54

Group type: COMPARATOR
Intervention: No intervention (IO-) - did not have a plate
Number of subjects: 54
Study: 11266253

Group type: EXPERIMENTAL
Intervention: Gentamicin laced collagen tampon
Number of subjects: 595

Group type: COMPARATOR
Intervention: Control group (no gentamicin laced collagen tampon)
Number of subjects: 595
Study: 9885199

Group type: EXPERIMENTAL
Intervention: Presence of a large mirror during tasting
Number of subjects: 0

Group type: COMPARATOR
Intervention: No mirror present during tasting
Number of subjects: 0
Study: 7983603

Group type: EXPERIMENTAL
Intervention: 900-mg theophylline doses as three 300-mg once-a-day theophylline capsules in the morning
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 900-mg theophylline doses as three 300-mg once-a-day theophylline capsules in the evening
Number of subjects: 18

Group type: COMPARATOR
Intervention: Matching placebo capsules administered midway between each dose of active drug
Number of subjects: 18
Study: 2660750

Group type: EXPERIMENTAL
Intervention: LC9018 alone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: LC9018 + MMC
Number of subjects: 29
Study: 8218753

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg t.d.s.; total dose 750 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 15
Study: 353720

Group type: EXPERIMENTAL
Intervention: Nomifensine (50-225 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 0
Study: 31419605

Group type: EXPERIMENTAL
Intervention: Systematic depression screening using the 8-item Patient Health Questionnaire (PHQ-8) and notification of primary care providers (PCPs) with invitation to participate in centralized, patient-preference, stepped depression care (Screen, Notify, and Treat)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Systematic depression screening and PCP notification only (Screen and Notify)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Usual care (No Screen)
Number of subjects: 1500
Study: 27664274

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 27753718

Group type: EXPERIMENTAL
Intervention: Self-reported risky drug use
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Amphetamines
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Opiates
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Cocaine
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Marijuana
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: History of incarceration
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 192
Study: 24577383

Group type: EXPERIMENTAL
Intervention: Early intensive blood pressure lowering
Number of subjects: 404

Group type: COMPARATOR
Intervention: Ambient temperature parameters
Number of subjects: 404
Study: 22901554

Group type: EXPERIMENTAL
Intervention: Lingonberry powder with glucose (50 g)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Lingonberry powder with triacylglycerols (35 g)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (fat-free yoghurt with glucose or triacylglycerols without lingonberry powder)
Number of subjects: 2
Study: 19876045

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo laser therapy
Number of subjects: 23
Study: 17877239

Group type: EXPERIMENTAL
Intervention: Triclosan dentifrice
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 15341616

Group type: EXPERIMENTAL
Intervention: 0.2% neutral sodium fluoride (NaF) mouthrinse
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX) mouthrinse
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 369
Study: 11605107

Group type: EXPERIMENTAL
Intervention: Voice-controlled robotic endoscope manipulator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human assistant
Number of subjects: 0
Study: 9825367

Group type: EXPERIMENTAL
Intervention: 2 mg SDZ WAG994 orally
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32